Donglei Zhu

Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)

Yunpeng Yang, Zhehai Wang, Jian Fang et al. · Journal of Thoracic Oncology · 2020 · 376 citations · Full text

Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial

Haiping Jiang, Yulong Zheng, Jiong Qian et al. · BMC Cancer · 2020 · 62 citations · Full text

Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression

Yonglin Lu, Yabin Ma, Chan Feng et al. · Journal of Cancer · 2019 · 44 citations · Full text

Targeted Delivery of Chlorin e6 via Redox Sensitive Diselenide-Containing Micelles for Improved Photodynamic Therapy in Cluster of Differentiation 44-Overexpressing Breast Cancer

Chan Feng, Donglei Zhu, Lv Chen et al. · Frontiers in Pharmacology · 2019 · 32 citations · Full text

Efficacy and safety of sintilimab in combination with chemotherapy in previously untreated advanced or metastatic nonsquamous or squamous NSCLC: two cohorts of an open-label, phase 1b study

Haiping Jiang, Yulong Zheng, Jiong Qian et al. · Cancer Immunology Immunotherapy · 2020 · 31 citations · Full text